CROs/Service Providers

Nordion enters into agreement to divest targeted therapies business to BTG

Wednesday, May 29, 2013 11:11 AM

Nordion, a provider of products and services for the prevention, diagnosis and treatment of disease, has entered into an agreement to divest its targeted therapies business to BTG, an international specialist healthcare company based in London, for a cash purchase price of $200 million. The transaction is anticipated to be completed by the end of June 2013.

More... »

Parexel opens Shenyang office

Tuesday, May 28, 2013 02:23 PM

Global CRO Parexel International has opened a new office in Shenyang, China, to support growing client demand for a broad range of clinical development capabilities throughout the Asia Pacific region. The office expands Parexel's presence in China, which includes locations in Beijing, Chengdu, Guangzhou, Shanghai and Hong Kong. PAREXEL now has 22 offices in the Asia Pacific region, including in Australia, Japan, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

More... »

Tufts CSDD study: Adoption of adaptive trials increasing

Tuesday, May 28, 2013 02:20 PM

Aptiv Solutions has announced publication of a Tufts Center for the Study of Drug Development (CSDD) report on the adoption and impact of adaptive trial designs, research funded by an unrestricted educational grant from Aptiv.

More... »

Avoca Group holds Quality Summit

Tuesday, May 28, 2013 02:11 PM

The Avoca Group, a Princeton, N.J.-based consulting and research organization specializing in clinical outsourcing and alliance management, held its second annual Avoca Quality Consortium Summit May 8 and 9. Last year, Avoca formed the industry‐wide Avoca Quality Consortium, bringing together quality, outsourcing and operational professionals from member pharma, biotech and CROs to accelerate the development of a best practice approach to quality management and oversight of outsourced clinical research.

More... »

PRA Holdings submits draft registration statement for IPO

Wednesday, May 22, 2013 10:27 AM

PRA Holdings, a global CRO, has submitted a confidential draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (SEC) for a possible initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.

More... »

ClinTec International expands in MENA region with planned Istanbul office

Wednesday, May 22, 2013 09:44 AM

ClinTec International, a global CRO with a presence in over 40 countries, plans to formally open an office in Istanbul, Turkey.

More... »

WIRB-Copernicus Group, Mytrus to deliver electronic informed consent solution

Wednesday, May 22, 2013 09:16 AM

The WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research, has partnered with Mytrus, a clinical technology and services company, to deliver a unique electronic informed consent solution that will help to streamline and enrich the clinical research process.

More... »

PRA opens new facility in Wales, creates 100 graduate-level jobs

Friday, May 17, 2013 02:03 PM

PRA, a global CRO, has officially opened its new facility in Swansea, Wales. The expansion is being supported with $1.9 million business finance from the Welsh government.

More... »

BioDuro opens state-of-the-art discovery lab in Shanghai

Friday, May 17, 2013 10:59 AM

BioDuro, a drug discovery services company owned by PPD, has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific.

More... »

Quintiles completes IPO of 27,236,841 shares of common stock

Wednesday, May 15, 2013 09:18 AM

Quintiles completed its initial public offering of 27,236,841 shares of its common stock at a price to the public of $40.00 per share.

More... »